At a glance
ClinicalIndex Comparison RecordN/ACompleted· 400 enrolled
Drug / intervention
Azithromycindrug
Likely dose
Azithromycin 30 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections
In Brief
An observational study evaluating Azithromycin for Respiratory Tract Infections. Completed, enrolled 400 participants.
Detailed Summary
The objective of this study was to obtain data on the safety, tolerability and compliance with Zithromax in children with bacterial infections of the upper and lower respiratory tract.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRespiratory Tract Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
Primary CompletionJan 2009
First PostedJul 2009
TodayJul 2026
First PostedJul 14, 2009
Enrollment StartApr 1, 2007
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.0 years ago
Interventions
Azithromycindrug
Zithromax was dispensed according to the Summary of Product Characteristics (SPC) as either a tablet or suspension. Zithromax was administered as a total dose of 30 mg/kg which was given as single daily doses of 10 mg/kg for 3 days, or as a 5 day dose starting with 10 mg/kg on Day 1, then 5 mg/kg on Days 2-5.